Redmond Asset Management, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 6 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Redmond Asset Management, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$180,000
-4.0%
75,0000.0%0.06%
+4.9%
Q2 2023$187,500
-56.0%
75,000
-50.0%
0.06%
-17.6%
Q1 2023$426,000
+195.8%
150,000
+100.0%
0.07%
+42.3%
Q4 2022$144,000
-33.0%
75,0000.0%0.05%
-35.0%
Q3 2022$215,000
+13.2%
75,0000.0%0.08%
+17.6%
Q2 2022$190,000
-51.3%
75,0000.0%0.07%
-41.4%
Q1 2022$390,000
+14.4%
75,0000.0%0.12%
+22.1%
Q4 2021$341,000
-6.1%
75,0000.0%0.10%
-16.7%
Q3 2021$363,000
+168.9%
75,0000.0%0.11%
+185.0%
Q2 2021$135,000
+68.8%
75,0000.0%0.04%
+60.0%
Q1 2021$80,00075,0000.02%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Privium Fund Management B.V. 122,084$361,3690.12%
K.J. Harrison & Partners Inc 170,750$505,4200.10%
Redmond Asset Management, LLC 150,000$426,0000.07%
ARMISTICE CAPITAL, LLC 375,001$1,110,0000.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders